Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Antitumor agent-74 is a quinazoline derivative and an antitumour agent. antitumor agent-74 in combination with the regional tautomer Antitumor agent-75 (compound 14 da) (mriBIQ 13da/14da) exhibits enhanced tumour inhibition. In particular, mriBIQ 13da/14da inhibits DNA synthesis, arrests the cell cycle in S phase and induces mitochondrial apoptosis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | Antitumor agent-74 is a quinazoline derivative and an antitumour agent. antitumor agent-74 in combination with the regional tautomer Antitumor agent-75 (compound 14 da) (mriBIQ 13da/14da) exhibits enhanced tumour inhibition. In particular, mriBIQ 13da/14da inhibits DNA synthesis, arrests the cell cycle in S phase and induces mitochondrial apoptosis. |
Molecular Weight | 438.5 |
Formula | C26H23FN6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Antitumor agent-74 inhibitor inhibit